Table 1 Baseline characteristics in 1606 CAD patients

Demographic data

 Age

63.03 ± 10.04

62.29 ± 10.18

 Sex (male)

828 (79.62)

419 (74.16)

 BMI, kg/m²

24.28 ± 4.79

24.06 ± 3.38

 SBP, mm Hg

130.66 ± 18.89

133.04 ± 20.29

 DBP, mm Hg

76.19 ± 11.03

76.46 ± 12.05

 Current smoking

294 (28.52)

160 (28.73)

 Family of CVD

29 (2.79)

–

Comorbidities

 Arrhythmia

92 (8.86)

51 (9.17)

 DM

286 (27.55)

164 (29.39)

 HyperT

627 (60.35)

340 (60.93)

 Dyslipidemia

729 (72.54)

400 (74.07)

Biomedical measurements

 ALT, U/L

27.41 ± 13.18

27.65 ± 24.56

 AST, U/L

26.64 ± 10.62

32.12 ± 55.48

 eGFR, mL/min/1.73 m²

94.32 ± 73.69

91.37 ± 110.84

 GLUC, mmol/L

6.74 ± 2.73

6.21 ± 3.82

 CHOL, mmol/L

4.28 ± 1.12

4.29 ± 1.77

 LDLC, mmol/L

2.58 ± 0.93

2.7 ± 1.00

 HDLC, mmol/L

0.97 ± 0.26

0.99 ± 0.25

 TRIG, mmol/L

1.62 ± 1.14

1.85 ± 1.85

 CKMB, U/L

7.48 ± 5.92

19.37 ± 52.83

 proBNP, pg/mL

774.51 ± 1597.35

1299.46 ± 4922.09

Medications

 BB

929 (89.5)

477 (84.57)

 ACEI

660 (63.58)

286 (50.71)

 CCB

295 (28.42)

165 (30.05)

 PPI

506 (48.75)

380 (67.26)

SYNTAX score

16.43 ± 10.74

16.45 ± 13.09

LVEF, %

60.1 ± 11.54

59.43 ± 11.63

LVMI, g/m²

122.13 ± 36.05

116.54 ± 35.08